by Within the sociology of well being and sickness, the heterogeneous discipline of heterodox medication is commonly conceptualised as a roughly homogeneous entity. Every kind of heterodox modes of therapy are pooled collectively with a view to uncover the heterodox affected person. On this manner, variations between a number of heterodox modes of therapy are misplaced and the rising image stays obscure. On this paper, we focus on one specific mode of therapy: Ayurveda.
Primarily based on 14 semi-structured interviews performed with the sufferers of German Ayurvedic physicians, we look at the paths that lead sufferers to this type of Asian medication, and the way they course of Ayurvedic ideas and make sense of them. Will probably be a narrative of how belief in heterodox medication is constructed and confirmed, a narrative of how international information is creatively acquired, modified and thus glocalised. We can even discover the sufferers’ notion of their relationships with their physicians, for the success of heterodox medication is commonly traced to a extra satisfying, private relationship with the doctor when in comparison with the somewhat temporary and technical consultations frequent in biomedicine.
Lastly, it’s argued that Ayurvedic sufferers don’t readily match the notion that heterodox sufferers are lively customers. In India, natural medicines are primarily primarily based on the Ayurvedic system. The principle disadvantage of conventional medicines is an absence of standardized merchandise. Standardization of any natural formulation is important with a view to assess the standard, purity, security, and efficacy of medication primarily based on the evaluation of their lively properties. Testing of Ayurvedic preparations utilizing scientific methodologies will add to high quality and authenticity of the product. This text studies standardization parameters for Hutabhugādi cūrṇa (HC) used historically within the therapy of Agnimāndya (digestive impairment), Pāndu (anemia), Sopha (edema), and Ārsa (piles).
Neuroprotective impact of Tagara, an Ayurvedic drug in opposition to methyl mercury induced oxidative stress utilizing rat mind mitochondrial fractions.
BACKGROUND
Methyl mercury (MeHg), an necessary environmental toxicant is implicated in neurological problems similar to Hunter-Russell syndrome and Autism. Subsequently, the current work is in quest of new medicine that may alleviate MeHg toxicity. On this connection, Tagara, an ayurvedic drug is used for assessing its neuro protecting impact in opposition to MeHg toxicity.
METHODS
Within the current examine, we assessed the phytochemical contents of Tagara by colorimetric and HPLC analyses. The neuroprotective impact of Tagara on MeHg induced neurotoxicity was measured when it comes to viability by MTT assay and oxidative stress when it comes to catalase exercise, glutathione and thiobarbituric acid reactive substance ranges. Additional, the chelating impact of Tagara in direction of MeHg was carried out to establish the molecular mechanism. Statistical evaluation was accomplished by statistical bundle for social sciences (SPSS) model 16.0.
RESULTS
The outcomes demonstrated that Tagara accommodates important quantities of phenols and flavonoids. Additionally, HPLC evaluation of Tagara revealed the presence of important oils similar to hydroxyvalerenic and valerenic acids. Our outcomes demonstrated that publicity of rat mind mitochondrial fractions to MeHg resulted in a dose dependent loss of life in MTT assay and IC50 worth was discovered to be 10 μM. Nonetheless, a 250 μg dose of Tagara successfully prevented MeHg induced mitochondrial injury. The oxidative stress attributable to MeHg leads to elevated ranges of reactive oxygen species as evidenced by elevated TBARS (Thiobarbituric acid-reactive substances) ranges and diminished catalase enzyme exercise and glutathione content material. Nonetheless, Tagara at 250 μg focus offsets these alterations attributable to MeHg. Additional, Tagara additionally diminished GSH oxidation attributable to MeHg, confirming its chelating impact, one of many molecular mechanisms that triggers safety in opposition to oxidative injury.
CONCLUSIONS
Our outcomes revealed that MeHg induced toxicity is predominantly mediated via oxidative stress mechanism and the propensity of Tagara to abolish such reactions. Therefore, we suggest that Tagara with a supply of potential neuroprotectants could also be a helpful strategy to alleviate MeHg related neurotoxicity.
Acute and power toxicity, cytochrome p450 enzyme inhibition, and HERG channel blockade research with a polyherbal, ayurvedic formulation for irritation.
Ayurvedic crops are identified for hundreds of years to have anti-inflammatory and antiarthritic impact. Now we have not too long ago proven that BV-9238, a proprietary formulation of Withania somnifera, Boswellia serrata, Zingiber officinale, and Curcuma longa, inhibits LPS-induced TNF-alpha and nitric oxide manufacturing from mouse macrophage and reduces irritation in several animal fashions. To guage the protection parameters of BV-9238, we performed a cytotoxicity examine in RAW 264.7 cells (0.005-1 mg/mL) by MTT/formazan technique, an acute single dose (2-10 g/kg body weight) toxicity examine and a 180-day power examine with 1 g and a pair of g/kg body weight in Sprague Dawley rats.
anti human CD14 |
|||
| 031-1-1.2 | Biometec GmbH | 100µl | EUR 110 |
anti human CD14 |
|||
| 031-1-5.2 | Biometec GmbH | 500µl | EUR 220 |
Anti‐Human FOXP3 |
|||
| E2790212 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
Anti‐Human IL‐17A |
|||
| E2790213 | EnoGene | 100ul | EUR 225 |
|
Description: Available in various conjugation types. |
|||
Rat anti Human IgG |
|||
| 40R-1588 | Fitzgerald | 100 ug | EUR 318 |
|
Description: Rat monoclonal Rat anti Human IgG antibody |
|||
Goat anti Human IgA |
|||
| 20-B9001G000-S0 | Fitzgerald | 10 ml | EUR 159.6 |
|
Description: Goat anti Human IgA antibody |
|||
Goat anti Human IgM |
|||
| 20-B9022G000-S2 | Fitzgerald | 10 ml | EUR 159.6 |
|
Description: Goat anti Human IgM antibody |
|||
Goat anti Human IgA |
|||
| 20-S11030GND1-D | Fitzgerald | 5 mg | EUR 230.4 |
|
Description: Goat anti Human IgA antibody |
|||
Goat anti Human IgA |
|||
| 20-S1103GND1-D0 | Fitzgerald | 10 ml | EUR 230.4 |
|
Description: Goat anti Human IgA antibody |
|||
Goat anti Human IgA |
|||
| 20-S1111G000-S4 | Fitzgerald | 10 ml | EUR 159.6 |
|
Description: Goat anti Human IgA antibody |
|||
Goat anti Human IgA |
|||
| 20-S1111G000-V0 | Fitzgerald | 10 ml | EUR 159.6 |
|
Description: Goat anti Human IgA antibody |
|||
Goat anti Human IgA |
|||
| 20-S1111GOOO-S4 | Fitzgerald | 10 ml | EUR 159.6 |
|
Description: Goat anti Human IgA antibody |
|||
Goat anti Human IgM |
|||
| 20-S1303GND1-D0 | Fitzgerald | 10 ml | EUR 230.4 |
|
Description: Goat anti Human IgM antibody |
|||
Goat anti Human IgM |
|||
| 20-S1304GA01 | Fitzgerald | 5 ml | EUR 165.6 |
|
Description: Goat anti Human IgM antibody |
|||
Goat anti Human IgM |
|||
| 20-S1311G000-S4 | Fitzgerald | 10 ml | EUR 159.6 |
|
Description: Goat anti Human IgM antibody |
|||
Goat anti Human IgM |
|||
| 20-S1311G000-V0 | Fitzgerald | 10 ml | EUR 133.2 |
|
Description: Goat anti Human IgM antibody |
|||
Goat anti Human IgM |
|||
| 20-S1311G001-S4 | Fitzgerald | 10 ml | EUR 159.6 |
|
Description: Goat anti Human IgM antibody |
|||
Goat anti Human IgE |
|||
| 20-S2001G000-S4 | Fitzgerald | 10 ml | EUR 152.4 |
|
Description: Goat anti Human IgE antibody |
|||
Goat anti Human IgE |
|||
| 20-S2001G000-V0 | Fitzgerald | 10 ml | EUR 159.6 |
|
Description: Goat anti Human IgE antibody |
|||
Goat anti Human IgE |
|||
| 20-S2001G000-VO | Fitzgerald | 10 ml | EUR 159.6 |
|
Description: Goat anti Human IgE antibody |
|||
Goat anti Human IgE |
|||
| 20-S2003GND1-D0 | Fitzgerald | 10 ml | EUR 230.4 |
|
Description: Goat anti Human IgE antibody |
|||
Goat anti Human IgM |
|||
| 20-S4113GN00-D4 | Fitzgerald | 10 ml | EUR 230.4 |
|
Description: Goat anti Human IgM antibody |
|||
Goat anti Human IgM |
|||
| 20-S5170GND1-D0 | Fitzgerald | 10 ml | EUR 230.4 |
|
Description: Goat anti Human IgM antibody |
|||
Goat anti Human IgA |
|||
| 20-S5491G000-S4 | Fitzgerald | 10 ml | EUR 159.6 |
|
Description: Goat anti Human IgA antibody |
|||
Goat anti Human IgE |
|||
| 40-IG10 | Fitzgerald | 1 ml | EUR 159.6 |
|
Description: Goat anti Human IgE antibody |
|||
Goat anti Human IgG |
|||
| 41C-CB0957 | Fitzgerald | 5 mg | EUR 415.2 |
|
Description: Goat anti Human IgG secondary antibody |
|||
Goat anti Human IgG |
|||
| 41C-CB0972 | Fitzgerald | 2 mg | EUR 316.8 |
|
Description: Goat anti Human IgG secondary antibody |
|||
Goat anti Human IgM |
|||
| 41C-CB0993 | Fitzgerald | 1 mg | EUR 244.8 |
|
Description: Goat anti Human IgM secondary antibody |
|||
Goat anti Human IgG |
|||
| 41R-1026 | Fitzgerald | 2 mg | EUR 164.4 |
|
Description: Goat anti Human IgG secondary antibody |
|||
Goat anti Human IgG |
|||
| 41R-1027 | Fitzgerald | 2 mg | EUR 223.2 |
|
Description: Goat anti Human IgG secondary antibody |
|||
Goat anti Human IgG |
|||
| 41R-1028 | Fitzgerald | 1 mg | EUR 218.4 |
|
Description: Goat anti Human IgG secondary antibody |
|||
Goat anti Human IgG |
|||
| 41R-1029 | Fitzgerald | 2 mg | EUR 223.2 |
|
Description: Goat anti Human IgG secondary antibody |
|||
Goat anti Human IgG |
|||
| 41R-1030 | Fitzgerald | 1 mg | EUR 165.6 |
|
Description: Goat anti Human IgG secondary antibody |
|||
Goat anti Human IgG |
|||
| 41R-1031 | Fitzgerald | 1 mg | EUR 223.2 |
|
Description: Goat anti Human IgG secondary antibody |
|||
Goat anti Human IgG |
|||
| 41R-1032 | Fitzgerald | 1 mg | EUR 268.8 |
|
Description: Goat anti Human IgG secondary antibody |
|||
Goat anti Human IgG |
|||
| 41R-1033 | Fitzgerald | 1 mg | EUR 295.2 |
|
Description: Goat anti Human IgG secondary antibody |
|||
Goat anti Human IgG |
|||
| 41R-1034 | Fitzgerald | 1 mg | EUR 223.2 |
|
Description: Goat anti Human IgG secondary antibody |
|||
Rat anti Human IgG1 |
|||
| 40R-1007 | Fitzgerald | 100 ug | EUR 318 |
|
Description: Rat monoclonal Rat anti Human IgG1 antibody |
|||
Goat anti Human IgG |
|||
| 41-XG56 | Fitzgerald | 1 mg | EUR 121.2 |
|
Description: Goat anti Human IgG secondary antibody |
|||
Goat anti Human IgE |
|||
| 70R-IG015 | Fitzgerald | 1 mg | EUR 418.8 |
|
Description: Affinity purified Goat anti Human IgE antibody |
|||
Goat anti Human IgM |
|||
| 70-B9022GA00-A0 | Fitzgerald | 5 mg | EUR 230.4 |
|
Description: Goat anti Human IgM antibody |
|||
Goat anti Human IgG |
|||
| 70C-CR6047GAP | Fitzgerald | 1 mg | EUR 178.8 |
|
Description: Affinity purified Goat anti Human IgG antibody |
|||
Goat anti- human IgA |
|||
| FNab09895 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against Goat human IgA |
|||
Goat anti- human IgG |
|||
| FNab09896 | FN Test | 100µg | Ask for price |
|
Description: Antibody raised against Goat human IgG |
|||
Goat anti- human IgM |
|||
| FNab09908 | FN Test | 100µg | EUR 658.5 |
|
Description: Antibody raised against Goat human IgM |
|||
Goat anti- human IgA |
|||
| LSMab09895 | Lifescience Market | 100 ug | EUR 525.6 |
Goat anti- human IgM |
|||
| LSMab09908 | Lifescience Market | 100 ug | EUR 525.6 |
Goat Anti Human IgG |
|||
| E61I00201 | EnoGene | 1mg | EUR 328.8 |
Goat Anti Human IgM |
|||
| E61I00401 | EnoGene | 100ug | EUR 411.6 |
Goat anti human IgA |
|||
| E61I01201 | EnoGene | 1mg | EUR 733.2 |
Goat anti human IgA |
|||
| E61I02102 | EnoGene | 100ug | EUR 411.6 |
FITC anti human CD3 |
|||
| E16FHF003-025 | EnoGene | 25 tests | EUR 89 |
|
Description: Available in various conjugation types. |
|||
FITC anti human CD3 |
|||
| E16FHF003-050 | EnoGene | 50 tests | EUR 127 |
|
Description: Available in various conjugation types. |
|||
FITC anti human CD3 |
|||
| E16FHF003-100 | EnoGene | 100 Tests | EUR 190.67 |
|
Description: Available in various conjugation types. |
|||
Goat anti Human IgA |
|||
| 20-1013 | Fitzgerald | 1 liter | Ask for price |
|
Description: Goat anti Human IgA antibody (Nephelometric and Turbidimetric grade) |
|||
Goat anti Human IgG |
|||
| 20-1014 | Fitzgerald | 1 liter | Ask for price |
|
Description: Goat anti Human IgG antibody (Nephelometric and Turbidimetric grade) |
|||
Goat anti Human IgM |
|||
| 20-1015 | Fitzgerald | 1 liter | Ask for price |
|
Description: Goat anti Human IgM antibody (Nephelometric and Turbidimetric grade) |
|||
Goat anti Human IgA |
|||
| 20-IG05 | Fitzgerald | 1 L | Ask for price |
|
Description: Goat anti Human IgA antibody |
|||
Goat anti Human IgG |
|||
| 20C-CR6047G | Fitzgerald | 1 L | Ask for price |
|
Description: Goat anti Human IgG antibody |
|||
Goat anti Human IgM |
|||
| 40-IG20 | Fitzgerald | 1 L | Ask for price |
|
Description: Goat anti Human IgM antibody |
|||
Goat anti Human IgM |
|||
| 40C-CR2023G | Fitzgerald | 1 L | Ask for price |
|
Description: Goat anti Human IgM antibody |
|||
Goat anti Human IgA |
|||
| 41-IG05 | Fitzgerald | 1 G | Ask for price |
|
Description: Goat anti Human IgA secondary antibody |
|||
Goat anti Human IgE |
|||
| 41-XG55 | Fitzgerald | 1 G | Ask for price |
|
Description: Affinity purified Goat anti Human IgE antibody |
|||
Goat anti human IgG |
|||
| 70-1097 | Fitzgerald | 1 mg | EUR 145 |
|
Description: Affinity Purified Goat anti human IgG polyclonal |
|||
Goat anti Human IgG |
|||
| 70-IG20 | Fitzgerald | 1 L | Ask for price |
|
Description: Purified Goat anti Human IgG antibody (Fc specific) |
|||
Goat anti Human IgE |
|||
| 70C-CR2021GAP | Fitzgerald | 1 G | Ask for price |
|
Description: Affinity purified Goat anti Human IgE antibody |
|||
anti- Human IgA antibody |
|||
| FNab04075 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against Human IgA |
|||
anti- Human IgA antibody |
|||
| FNab04076 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against Human IgA |
|||
anti- Human IgG antibody |
|||
| FNab04077 | FN Test | 100µg | EUR 702 |
|
Description: Antibody raised against Human IgG |
|||
human anti-human CD3 mAb |
|||
| E4A09C01 | EnoGene | 50ug | EUR 255 |
|
Description: Available in various conjugation types. |
|||
human anti-human CD4 mAb |
|||
| E4A09C02 | EnoGene | 50ug | EUR 255 |
|
Description: Available in various conjugation types. |
|||
human anti-human CD8 mAb |
|||
| E4A09C03 | EnoGene | 50ug | EUR 255 |
|
Description: Available in various conjugation types. |
|||
human anti-human CD9 mAb |
|||
| E4A09C04 | EnoGene | 50ug | EUR 255 |
|
Description: Available in various conjugation types. |
|||
human anti-human C5a mAb |
|||
| E4A09D01 | EnoGene | 50ug | EUR 255 |
|
Description: Available in various conjugation types. |
|||
human anti-human NGF mAb |
|||
| E4A09D17 | EnoGene | 50ug | EUR 255 |
|
Description: Available in various conjugation types. |
|||
human anti-human SAA mAb |
|||
| E4A09E01 | EnoGene | 50ug | EUR 255 |
|
Description: Available in various conjugation types. |
|||
human anti-human PCT mAb |
|||
| E4A09E02 | EnoGene | 50ug | EUR 255 |
|
Description: Available in various conjugation types. |
|||
human anti-human CD4 mAb |
|||
| E409C02-h100 | EnoGene | 100μL | EUR 395 |
|
Description: Available in various conjugation types. |
|||
human anti-human CD9 mAb |
|||
| E409C03-h100 | EnoGene | 100μL | EUR 395 |
|
Description: Available in various conjugation types. |
|||
human anti-human NGF mAb |
|||
| E409C33-h100 | EnoGene | 100μL | EUR 395 |
|
Description: Available in various conjugation types. |
|||
Mouse anti Human IgE |
|||
| 10-1025 | Fitzgerald | 1 mg | EUR 392.4 |
|
Description: Mouse monoclonal Mouse anti Human IgE antibody |
|||
Mouse anti Human IgE |
|||
| 10-1026 | Fitzgerald | 1 mg | EUR 392.4 |
|
Description: Mouse monoclonal Mouse anti Human IgE antibody |
|||
Mouse anti Human IgE |
|||
| 10-1027 | Fitzgerald | 1 mg | EUR 392.4 |
|
Description: Mouse monoclonal Mouse anti Human IgE antibody |
|||
Mouse anti Human IgA |
|||
| 10-7808 | Fitzgerald | 1 mg | EUR 403.2 |
|
Description: Mouse anti Human IgA antibody |
|||
Mouse anti Human IgA |
|||
| 10-I05A | Fitzgerald | 1 mg | EUR 369.6 |
|
Description: Mouse anti Human IgA antibody |
|||
Mouse anti Human IgE |
|||
| 10-I104B | Fitzgerald | 1 mg | EUR 403.2 |
|
Description: Mouse anti Human IgE antibody |
|||
Mouse anti Human IgE |
|||
| 10-I104CC | Fitzgerald | 1 mg | EUR 403.2 |
|
Description: Mouse anti Human IgE antibody |
|||
Mouse anti Human IgE |
|||
| 10-I10A | Fitzgerald | 1 mg | EUR 217.2 |
|
Description: Mouse anti Human IgE antibody |
|||
Mouse anti Human IgE |
|||
| 10-I10C | Fitzgerald | 1 mg | EUR 217.2 |
|
Description: Mouse anti Human IgE antibody |
|||
Mouse anti Human IgE |
|||
| 10-I10E | Fitzgerald | 1 mg | EUR 594 |
|
Description: Mouse anti Human IgE antibody |
|||
Mouse anti Human IgM |
|||
| 10-I20A | Fitzgerald | 1 mg | EUR 229.2 |
|
Description: Mouse anti Human IgM antibody |
|||
Mouse anti Human IgM |
|||
| 10-I20B | Fitzgerald | 1 mg | EUR 354 |
|
Description: Mouse anti Human IgM antibody |
|||
Mouse anti Human IgM |
|||
| 10-I20G | Fitzgerald | 1 mg | EUR 354 |
|
Description: Mouse anti Human IgM antibody |
|||
Mouse anti Human IgM |
|||
| 10-I20H | Fitzgerald | 1 mg | EUR 224.4 |
|
Description: Mouse anti Human IgM antibody |
|||
Mouse anti Human IgE |
|||
| 10-S9601MND1-M0 | Fitzgerald | 1 mg | EUR 262.8 |
|
Description: Mouse anti Human IgE antibody |
|||
Mouse anti Human IgM |
|||
| 10C-CR2023M2 | Fitzgerald | 1 mg | EUR 184.8 |
|
Description: Mouse anti Human IgM antibody |
|||
Mouse anti Human IgM |
|||
| 10C-CR2023M3 | Fitzgerald | 1 mg | EUR 184.8 |
|
Description: Mouse anti Human IgM antibody |
|||
Mouse anti Human IgA |
|||
| 10C-CR6043M1 | Fitzgerald | 1 mg | EUR 289.2 |
|
Description: Mouse anti Human IgA antibody |
|||
Mouse anti Human IgE |
|||
| 10C-CR6046M3 | Fitzgerald | 1 mg | EUR 198 |
|
Description: Mouse anti Human IgE antibody |
|||
Mouse anti Human IgE |
|||
| 10C-CR6046M4 | Fitzgerald | 1 mg | EUR 198 |
|
Description: Mouse anti Human IgE antibody |
|||
Mouse anti Human IgE |
|||
| 10C-CR6046M5 | Fitzgerald | 1 mg | EUR 198 |
|
Description: Mouse anti Human IgE antibody |
|||
Mouse anti Human IgG |
|||
| 10C-CR6047M1 | Fitzgerald | 1 mg | EUR 211.2 |
|
Description: Mouse anti Human IgG antibody |
|||
Mouse anti Human IgG |
|||
| 10C-CR6047M2 | Fitzgerald | 1 mg | EUR 211.2 |
|
Description: Mouse anti Human IgG antibody |
|||
Mouse anti Human IgE |
|||
| 10R-I104d | Fitzgerald | 1 mg | EUR 536.4 |
|
Description: Mouse anti Human IgE antibody |
|||
Mouse anti Human IgE |
|||
| 10R-I104e | Fitzgerald | 1 mg | EUR 586.8 |
|
Description: Mouse anti Human IgE antibody |
|||
Mouse anti Human IgM |
|||
| 10R-I130a | Fitzgerald | 1 mg | EUR 382.8 |
|
Description: Mouse anti Human IgM antibody |
|||
Mouse anti Human IgM |
|||
| 10R-I130B | Fitzgerald | 1 mg | EUR 360 |
|
Description: Mouse anti Human IgM antibody |
|||
Sheep anti Human IgA |
|||
| 20C-CR6043SP | Fitzgerald | 1 ml | EUR 265.2 |
|
Description: Sheep anti Human IgA antibody |
|||
Sheep anti Human IgA |
|||
| 20C-CR6043SP-S | Fitzgerald | 1 ml | EUR 265.2 |
|
Description: Sheep anti Human IgA antibody |
|||
Sheep anti Human IgA |
|||
| 20-1266 | Fitzgerald | 1ml | EUR 776.4 |
|
Description: Sheep polyclonal Human IgA secondary antibody |
|||
Sheep anti Human IgG |
|||
| 20-1377 | Fitzgerald | 1ml | EUR 5667.6 |
|
Description: Sheep polyclonal Human IgG secondary antibody |
|||
Sheep anti Human IgE |
|||
| 40-IG11 | Fitzgerald | 1 ml | EUR 159.6 |
|
Description: Sheep anti Human IgE antibody |
|||
Mouse anti Human IgE |
|||
| 40R-1000 | Fitzgerald | 100 ug | EUR 318 |
|
Description: Mouse anti Human IgE antibody |
|||
Mouse anti Human IgA |
|||
| 40R-1001 | Fitzgerald | 100 ug | EUR 318 |
|
Description: Mouse anti Human IgA antibody |
|||
Mouse anti Human IgM |
|||
| 41R-1586 | Fitzgerald | 100 ug | EUR 318 |
|
Description: Monoclonal Mouse anti Human IgM antibody |
|||
Sheep anti Human IgM |
|||
| 40C-CR2023S | Fitzgerald | 1 ml | EUR 289.2 |
|
Description: Sheep anti Human IgM antibody |
|||
Mouse anti Human IgG |
|||
| 40R-1003 | Fitzgerald | 100 ug | EUR 318 |
|
Description: Mouse anti Human IgG antibody |
|||
Mouse anti Human IgE |
|||
| 40R-1004 | Fitzgerald | 100 ug | EUR 318 |
|
Description: Mouse anti Human IgE antibody |
|||
Mouse anti Human IgM |
|||
| 40R-1005 | Fitzgerald | 100 ug | EUR 318 |
|
Description: Mouse anti Human IgM antibody |
|||
Mouse anti Human IgA |
|||
| 40R-1006 | Fitzgerald | 100 ug | EUR 318 |
|
Description: Mouse anti Human IgA antibody |
|||
Mouse anti Human IgA |
|||
| 40R-1011 | Fitzgerald | 500 ug | EUR 678 |
|
Description: Mouse anti Human IgA secondary antibody |
|||
Mouse anti Human IgA |
|||
| 40R-1012 | Fitzgerald | 500 ug | EUR 678 |
|
Description: Mouse anti Human IgA secondary antibody |
|||
Mouse Anti Human IgM |
|||
| E61I00402 | EnoGene | 100ug | EUR 411.6 |
Mouse anti human IgA |
|||
| E61I02101 | EnoGene | 100ug | EUR 411.6 |
Mouse anti human IgE |
|||
| E61I02201 | EnoGene | 100ug | EUR 411.6 |
Human Anti-Insulin Anti-body(Anti-Ins) ELISA Kit |
|||
| NSL1084Hu | Sunlong | 96 wells | EUR 468 |
Mouse anti Human IgG1 |
|||
| 10-I21A | Fitzgerald | 200 ug | EUR 264 |
|
Description: Mouse anti Human IgG1 antibody |
|||
Mouse anti Human IgG2 |
|||
| 10-I22A | Fitzgerald | 200 ug | EUR 470.4 |
|
Description: Mouse anti Human IgG2 antibody |
|||
Mouse anti Human IgG3 |
|||
| 10-I23A | Fitzgerald | 200 ug | EUR 762 |
|
Description: Mouse anti Human IgG3 antibody |
|||
Mouse anti Human IgG4 |
|||
| 10-I24A | Fitzgerald | 200 ug | EUR 470.4 |
|
Description: Mouse anti Human IgG4 antibody |
|||
Mouse anti Human IgG1 |
|||
| 10R-I110a | Fitzgerald | 1 ml | EUR 664.8 |
|
Description: Mouse anti Human IgG1 antibody |
|||
Mouse anti Human IgG1 |
|||
| 10R-I127a | Fitzgerald | 1 mg | EUR 586.8 |
|
Description: Mouse anti Human IgG1 antibody |
|||
Mouse anti Human IgG2 |
|||
| 10R-I128a | Fitzgerald | 1 mg | EUR 586.8 |
|
Description: Mouse anti Human IgG2 antibody |
|||
Mouse anti Human IgG4 |
|||
| 10R-I129a | Fitzgerald | 1 mg | EUR 573.6 |
|
Description: Mouse anti Human IgG4 antibody |
|||
Rabbit anti Human IgE |
|||
| 20-IR77 | Fitzgerald | 1 ml | EUR 230.4 |
|
Description: Rabbit anti Human IgE antibody |
|||
Rabbit anti Human IgG |
|||
| 40C-CB0943 | Fitzgerald | 1 mg | EUR 298.8 |
|
Description: Rabbit anti Human IgG secondary antibody |
|||
Rabbit anti Human IgG |
|||
| 40C-CB0950 | Fitzgerald | 5 mg | EUR 457.2 |
|
Description: Rabbit anti Human IgG secondary antibody |
|||
Rabbit anti Human IgG |
|||
| 40C-CB0971 | Fitzgerald | 2 mg | EUR 386.4 |
|
Description: Rabbit anti Human IgG secondary antibody |
|||
Rabbit anti Human IgM |
|||
| 40C-CB9100 | Fitzgerald | 2 mg | EUR 339.6 |
|
Description: Rabbit anti Human IgM secondary antibody |
|||
Rabbit anti Human IgA |
|||
| 40C-CB9114 | Fitzgerald | 2 mg | EUR 310.8 |
|
Description: Rabbit anti Human IgA secondary antibody |
|||
Mouse anti Human IgG3 |
|||
| 40R-1015 | Fitzgerald | 1 mg | EUR 496.8 |
|
Description: Mouse anti Human IgG3 antibody |
|||
Rabbit Anti Human IgG |
|||
| E61I00101 | EnoGene | 100ug | EUR 411.6 |
human anti-human CD19 mAb |
|||
| E4A09C07 | EnoGene | 50ug | EUR 255 |
|
Description: Available in various conjugation types. |
|||
Some sedation, ptosis, and ataxia had been noticed for first 15-20 min in very excessive acute doses and therefore not used for additional power research. On the finish of 180 days, gross and histopathology, blood cell counts, liver and renal features had been all at regular ranges. Additional, a modest try was made to evaluate the results of BV-9238 (0.5 µg/mL) on six main human cytochrome P450 enzymes and (3)H radioligand binding assay with human hERG receptors. BV-9238 didn’t present any important inhibition of those enzymes on the examined dose. All these recommend that BV-9238 has potential as a protected and properly tolerated anti-inflammatory formulation for future use.
